Isolating Cognitive and Neurologic HIV Effects in Substance-Dependent, Confounded Cohorts: A Pilot Study

Abstract Controversy exists as to whether effects of HIV infection can be detected in the cognitive profiles of substance users, with methodological differences in degree of control for confounding factors a major contributor to empirical discrepancies. To address this shortcoming, we conducted a small but well-controlled study aimed at isolating HIV neurocognitive (NC) effects in a group of chronic substance users. Thirty HIV-negative substance users were individually matched to 30 HIV-positive substance users on relevant medical and demographic factors, including reading level and methadone therapy status. Results revealed that reading level, methadone maintenance therapy, and positive urine toxicology each exerted significant influence on NC function, and that HIV status was a significant predictor of learning and speeded processing after these control factors were considered. The HIV-positive group also displayed significantly more neurologically assessed motor impairment (p < .05), which was specifically related to impaired cognition in this group and independent of degree of immunocompromise. These data demonstrate the need for increased attention to clinical/demographic characteristics of groups under study. They also show that with applied methodological rigor, the deleterious effects of HIV on cognition can be parsed from substance use, even in small samples with chronic and active use histories. (JINS, 2013, 19, 1–11)

[1]  D. Vlahov,et al.  Effect of chronic substance abuse on the neuropsychological performance of intravenous drug users with a high prevalence of HIV-1 seropositivity. , 1992, American journal of epidemiology.

[2]  Julie Barroso,et al.  Changes in Neuropsychological Functioning with Progression of HIV-1 Infection: Results of an 8-Year Longitudinal Investigation , 2004, AIDS and Behavior.

[3]  C. Newton,et al.  Microbial Infections, Immunomodulation, and Drugs of Abuse , 2003, Clinical Microbiology Reviews.

[4]  Xuchu Weng,et al.  Gray matter density negatively correlates with duration of heroin use in young lifetime heroin-dependent individuals , 2009, Brain and Cognition.

[5]  R. Stickgold,et al.  Cocaine Users Differ from Normals on Cognitive Tasks Which Show Poorer Performance During Drug Abstinence , 2008, The American journal of drug and alcohol abuse.

[6]  F. Crawford,et al.  Cocaine-induced oxidative stress precedes cell death in human neuronal progenitor cells , 2007, Neurochemistry International.

[7]  G. Pearlson,et al.  Decreased frontal white-matter volume in chronic substance abuse. , 2005, The international journal of neuropsychopharmacology.

[8]  P. Simmonds,et al.  HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement. , 1998, Brain : a journal of neurology.

[9]  D. Simpson,et al.  Motor function and human immunodeficiency virus-associated cognitive impairment in a highly active antiretroviral therapy-era cohort. , 2008, Archives of neurology.

[10]  K. Boone,et al.  A meta-analysis of the neuropsychological sequelae of HIV infection , 2002, Journal of the International Neuropsychological Society.

[11]  I. Grant,et al.  Neurocognitive Effects of Methamphetamine: A Critical Review and Meta-analysis , 2007, Neuropsychology Review.

[12]  R. Bornstein,et al.  Effects of Past Noninjection Drug Abuse Upon Executive Function and Working Memory in HIV Infection , 2003, Journal of clinical and experimental neuropsychology.

[13]  J. Bell,et al.  Neurobiology of Multiple Insults: HIV-1-Associated Brain Disorders in Those Who Use Illicit Drugs , 2006, Journal of Neuroimmune Pharmacology.

[14]  M. Verfaellie,et al.  Chronic Postconcussion Symptoms and Functional Outcomes in OEF/OIF Veterans with Self-Report of Blast Exposure , 2012, Journal of the International Neuropsychological Society.

[15]  L. Prockop AIDS dementia complex. , 1988, The Journal of legal medicine.

[16]  A. Bechara,et al.  Delayed nonmatch-to-sample performance in HIV-seropositive and HIV-seronegative polydrug abusers. , 2003, Neuropsychology.

[17]  Y. Stern,et al.  Reading level attenuates differences in neuropsychological test performance between African American and White elders , 2002, Journal of the International Neuropsychological Society.

[18]  H. Myers,et al.  Discrepancies between self-report and objective measures for stimulant drug use in HIV: cognitive, medication adherence and psychological correlates. , 2007, Addictive behaviors.

[19]  M. Pérez-García,et al.  Neuropsychological consequences of alcohol and drug abuse on different components of executive functions , 2010, Journal of psychopharmacology.

[20]  Michael J. Taylor,et al.  HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy , 2010, Neurology.

[21]  A. Büttner,et al.  Review: The neuropathology of drug abuse , 2011, Neuropathology and applied neurobiology.

[22]  D. Byrd,et al.  Distal Sensory Polyneuropathy is Associated with Neuropsychological Test Performance among Persons with HIV , 2012, Journal of the International Neuropsychological Society.

[23]  K. Hennig-Fast,et al.  Cognitive Functioning During Methadone and Buprenorphine Treatment: Results of a Randomized Clinical Trial , 2008, Journal of clinical psychopharmacology.

[24]  J. Endicott,et al.  Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers. , 1996, The American journal of psychiatry.

[25]  K. Welch Neurological complications of alcohol and misuse of drugs , 2011, Practical Neurology.

[26]  E. Masliah,et al.  Cognitive deficits and degeneration of interneurons in HIV+ methamphetamine users , 2006, Neurology.

[27]  E. Daar Faculty Opinions recommendation of HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. , 2011 .

[28]  E. Ryan,et al.  Neuropsychological impairment in racial/ethnic minorities with HIV infection and low literacy levels: Effects of education and reading level in participant characterization , 2005, Journal of the International Neuropsychological Society.

[29]  B. Navia,et al.  The AIDS dementia complex: I. Clinical features , 1986, Annals of neurology.

[30]  A. Nath,et al.  Neurologic complications: Challenges to the diagnosis and management of HIV dementia , 2006 .

[31]  M. Hillbom,et al.  Neurological complications of drug abuse: pathophysiological mechanisms , 2000, European journal of neurology.

[32]  M. Stitzer,et al.  Opioid abuse and cognitive performance. , 2005, Drug and alcohol dependence.

[33]  A. Venkatesan,et al.  Adult hippocampal neurogenesis: regulation by HIV and drugs of abuse , 2007, Cellular and Molecular Life Sciences.

[34]  M. Stitzer,et al.  Cognitive impairment in methadone maintenance patients. , 2002, Drug and alcohol dependence.

[35]  D. Simpson,et al.  HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank. , 2004, Archives of neurology.

[36]  I. Grant,et al.  Neurocognitive Impact of Substance Use in HIV Infection , 2011, Journal of acquired immune deficiency syndromes.

[37]  S. McDonald,et al.  Comparative patterns of cognitive performance amongst opioid maintenance patients, abstinent opioid users and non-opioid users. , 2012, Drug and alcohol dependence.

[38]  R. Bornstein,et al.  Neurobehavioural consequences of substance abuse and HIV infection , 2000, Journal of psychopharmacology.

[39]  M. Cherner,et al.  Co-factors in HIV neurobehavioural disturbances: Substance abuse, hepatitis C and aging , 2008, International review of psychiatry.

[40]  Y. Stern,et al.  Literacy and cognitive change among ethnically diverse elders , 2004 .

[41]  E. Miller,et al.  The Effect of Recent Stimulant Use on Sustained Attention in HIV-Infected Adults , 2006, Journal of clinical and experimental neuropsychology.

[42]  G. Sobue,et al.  Alcoholic neuropathy is clinicopathologically distinct from thiamine‐deficiency neuropathy , 2003, Annals of neurology.

[43]  J. Prager,et al.  CNS complications of cocaine abuse: prevalence, pathophysiology, and neuroradiology. , 1992, AJR. American journal of roentgenology.

[44]  H. Morgenstern,et al.  HIV-1, cocaine, and neuropsychological performance in African American men , 2000, Journal of the International Neuropsychological Society.

[45]  M. Pérez-García,et al.  Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers. , 2005, Drug and alcohol dependence.

[46]  Hugh Garavan,et al.  Acute effects of cocaine on the neurobiology of cognitive control , 2008, Philosophical Transactions of the Royal Society B: Biological Sciences.

[47]  Y. Stern,et al.  Cognitive test performance among nondemented elderly African Americans and whites , 1998, Neurology.

[48]  R. Paul,et al.  Drug Abuse and Hepatitis C Infection as Comorbid Features of HIV Associated Neurocognitive Disorder: Neurocognitive and Neuroimaging Features , 2009, Neuropsychology Review.

[49]  Zhening Liu,et al.  Frontal and cingulate gray matter volume reduction in heroin dependence: Optimized voxel‐based morphometry , 2009, Psychiatry and clinical neurosciences.

[50]  W. V. Gorp,et al.  Neuropsychology and substance use : state-of-the-art and future directions. , 2007 .

[51]  K. Tashima,et al.  Neurocognitive Effects of HIV, Hepatitis C, and Substance Use History , 2011, Journal of the International Neuropsychological Society.

[52]  Andrew J. Saykin,et al.  Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus‐type 1 (HIV‐1) infection , 1991, Neurology.

[53]  A. Bhalla,et al.  Recreational drug misuse and stroke. , 2011, Current drug abuse reviews.

[54]  C. Sherbourne,et al.  Use of mental health and substance abuse treatment services among adults with HIV in the United States. , 2001, Archives of general psychiatry.

[55]  T. Lundqvist,et al.  Imaging cognitive deficits in drug abuse. , 2010, Current topics in behavioral neurosciences.

[56]  J. Becker,et al.  Slowed Information Processing in HIV-1 Disease , 1998 .

[57]  C. Sherbourne,et al.  Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. , 2001, Archives of general psychiatry.

[58]  I. Grant,et al.  Interrater Reliability of Clinical Ratings and Neurocognitive Diagnoses in HIV , 2004, Journal of clinical and experimental neuropsychology.

[59]  D. Vlahov,et al.  Comparison of neuropsychological performance between AIDS-free injecting drug users and homosexual men. , 1997, Neuroepidemiology.

[60]  Deborah A. Yurgelun-Todd,et al.  Neuropsychological Consequences of Opiate Use , 2007, Neuropsychology Review.

[61]  Douglas A. Weigmann,et al.  Methamphetamine effects on cognitive processing during extended wakefulness. , 1996, The International journal of aviation psychology.

[62]  L. Provinciali,et al.  Cognitive behavior in asymptomatic (CDC stage II and III) HIV — seropositive intravenous drug users (IVDUs) , 1993, The Italian Journal of Neurological Sciences.

[63]  Y. Challenor,et al.  Neurological complications of addiction to heroin. , 1973, Bulletin of the New York Academy of Medicine.

[64]  I. Grant,et al.  Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons , 2004, Journal of the International Neuropsychological Society.